| [Fire Fighting] Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire. | |
| [Ingestion] Acute exposure - activated charcoal: administer charcoal as a slurry (240 ml water/30 g charcoal). Usual dose: 25 to 100 g in adults/adolescents. Consider gastric lavage in patients with recent ingestion of liquid or powdered products. | |
| [Inhalation] If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention. | |
| [Skin] Remove contaminated clothing. Wash exposed area with soap and water. If symptoms persist, seek medical attention. Launder clothing before reuse. | |
| [Eyes] If symptoms develop, immediately move individual away from exposure and into fresh air. Flush eyes gently with water for at least 15 minutes while holding eyelids apart; seek immediate medical attention. | |
| [Storage] Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage. | |
| [Handling] All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood. | |
| [Ingestion] Chronic lead exposure: abdominal pain, nausea, anorexia, vomiting, constipation, diarrhea, and a metallic taste in the mouth have been reported with chronic toxicity. Severe and paroxysmal colic characterized by a rigid and retracted abdomen may occur. | |
| [Personal Protection] Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots. | |
| [Respirators] Use NIOSH/MSHA approved respirator appropriate for exposure of concern. | |
| [Exposure Effects] Chronic lead exposure may cause elevated blood pressure and gout. In young children, developmental defects, including learning disabilities and behavioral abnormalities, can occur without symptoms at blood lead levels above 10 micrograms/deciliter. At higher levels of exposure headache, fatigue, irritability and malaise may occur. At high levels, encephalopathy, seizures and focal neurologic findings with imminent risk of death, permanent mental retardation, and motor deficits may occur. Lead is transferred across the placenta. It can affect reproduction in males and females, and affects neurodevelopmental milestones in children with both prenatal and postnatal exposure. | |
| [Exposure limit(s)] TLV (as Pb): ppm; 0.05 mg/m3 A3 (ACGIH 1996). MAK: ppm; 0.1 mg/m3; as Pb (1996). | |
| [Poison Class] 1 | |
| [Appearance] Semi-transparent, yellow paste. | |
| [Solubility in water] Insoluble | |
| [Density] 1.13 g/cm3 | |
| [Usage] Varnish drier, catalyst for reaction between unsaturated fatty acids & sulfates in presence of air, lube oil additive. | |
| [Product Name] Lead naphthenate | |
| [Synonyms] Cyclohexanecarboxylic acid, lead salt Naphthenic acid, lead salt | |
| [CAS] "CASEN_61790-14-5.htm">61790-14-5 | |
| [EINECS] 263-109-4 | |
| [RTECS] QK9150000 | |
| [RTECS Class] Tumorigen | |
| [Beilstein/Gmelin] NA | |
| [Small spills/leaks] Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces. | |
| [Stability] No data. | |
| [Incompatibilities] Strong oxidizing agents. | |
| [Decomposition] When heated to decomposition, it emits toxic fumes of lead. |
Print